Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Lenalidomide
Locations
1
China
Nanfang hospital
Guangzhou, Guangdong, China
Start Date
October 1, 2020
Primary Completion Date
October 1, 2022
Completion Date
October 1, 2024
Last Updated
September 10, 2020
NCT05006716
NCT06026319
NCT07368270
NCT07255963
NCT05940272
NCT06352242
Lead Sponsor
Nanfang Hospital, Southern Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions